ALBUMIN (HUMAN)

ALBUMIN (HUMAN) was reported 5486 times

ALBUMIN (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACCESSORY MUSCLE 3 0.5000
1 KIDNEY MALROTATION 6 0.1463
2 PERIUMBILICAL ABSCESS 8 0.1194
3 MECHANICAL VENTILATION COMPLICATION 12 0.0805
4 CARDIAC PSEUDOANEURYSM 4 0.0580
5 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 14 0.0579
6 TRANSFUSION-RELATED ACUTE LUNG INJURY 15 0.0487
7 CATHETER SITE ABSCESS 8 0.0460
8 MONOCYTOSIS 28 0.0451
9 INSPIRATORY CAPACITY DECREASED 12 0.0433
10 PHOSPHOLIPIDOSIS 4 0.0404
11 ALLERGIC TRANSFUSION REACTION 6 0.0397
12 CARDIAC CIRRHOSIS 4 0.0388
13 PLEURAL CALCIFICATION 4 0.0348
14 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 6 0.0319
15 PORTAL TRACT INFLAMMATION 4 0.0317
16 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 29 0.0306
17 CELL-MEDIATED IMMUNE DEFICIENCY 4 0.0286
18 CERVIX CARCINOMA RECURRENT 5 0.0281
19 POSTOPERATIVE RENAL FAILURE 4 0.0276
20 SYMBLEPHARON 7 0.0268
21 HEPATIC VEIN OCCLUSION 4 0.0253
22 MORGANELLA INFECTION 7 0.0239
23 TRI-IODOTHYRONINE FREE DECREASED 6 0.0235
24 MULTISYSTEM INFLAMMATORY SYNDROME 4 0.0231
25 VAGINAL LESION 7 0.0229
26 URINARY TRACT INFLAMMATION 8 0.0222
27 CONDUCTIVE DEAFNESS 7 0.0218
28 HYPOPROTEINAEMIA 36 0.0190
29 PORTAL FIBROSIS 4 0.0187
30 CANDIDA PNEUMONIA 6 0.0186
31 HISTAMINE LEVEL INCREASED 4 0.0184
32 CAPILLARY LEAK SYNDROME 37 0.0179
33 EXPOSURE TO SARS-COV-2 27 0.0159
34 NECROTISING COLITIS 20 0.0158
35 BONE MARROW INFILTRATION 6 0.0155
36 RED BLOOD CELL SCHISTOCYTES PRESENT 5 0.0154
37 MORAXELLA INFECTION 4 0.0146
38 WRONG PRODUCT STORED 4 0.0141
39 HAEMORRHAGIC ASCITES 4 0.0140
40 EPIDERMOLYSIS 6 0.0130
41 GASTROENTERITIS ROTAVIRUS 4 0.0130
42 INCREASED DOSE ADMINISTERED 4 0.0128
43 HAEMOPERITONEUM 10 0.0125
44 HYPOALBUMINAEMIA 96 0.0123
45 NEUROPSYCHOLOGICAL SYMPTOMS 7 0.0116
46 HYPERPYREXIA 49 0.0116
47 PRODUCT INEFFECTIVE 9 0.0115
48 DELAYED GRAFT FUNCTION 8 0.0113
49 CARDIOVASCULAR INSUFFICIENCY 18 0.0110
50 HUMORAL IMMUNE DEFECT 4 0.0108
51 LUNG INFECTION PSEUDOMONAL 6 0.0108
52 PANCREATIC PSEUDOCYST 8 0.0103
53 MULTI-ORGAN FAILURE 175 0.0101
54 ULCERATIVE KERATITIS 27 0.0098
55 BLOOD FIBRINOGEN DECREASED 11 0.0096
56 OSMOTIC DEMYELINATION SYNDROME 7 0.0095
57 ACINETOBACTER INFECTION 10 0.0091
58 ABDOMINAL SEPSIS 8 0.0091
59 PORTAL HYPERTENSIVE GASTROPATHY 5 0.0089
60 TUMOUR FLARE 6 0.0088
61 URINARY TRACT INFECTION FUNGAL 5 0.0087
62 ENTEROCOCCAL SEPSIS 7 0.0086
63 SKIN TEST POSITIVE 8 0.0086
64 PANCREATITIS RELAPSING 7 0.0086
65 KLEBSIELLA INFECTION 43 0.0085
66 ENGRAFTMENT SYNDROME 5 0.0085
67 ADENOMA BENIGN 7 0.0081
68 FEAR 219 0.0081
69 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 10 0.0080
70 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 30 0.0078
71 HEPATORENAL SYNDROME 13 0.0077
72 TACHYPNOEA 104 0.0076
73 ENCEPHALITIS AUTOIMMUNE 10 0.0076
74 RETROPERITONEAL LYMPHADENOPATHY 4 0.0076
75 LUNG TRANSPLANT REJECTION 5 0.0076
76 TOXIC EPIDERMAL NECROLYSIS 112 0.0074
77 LIVEDO RETICULARIS 15 0.0072
78 PROTEUS INFECTION 5 0.0070
79 HILAR LYMPHADENOPATHY 6 0.0068
80 CRYSTAL NEPHROPATHY 4 0.0068
81 RESPIRATORY TRACT HAEMORRHAGE 4 0.0067
82 RENAL INJURY 197 0.0066
83 HAEMOTHORAX 19 0.0065
84 BILIARY TRACT INFECTION 4 0.0064
85 KIDNEY ENLARGEMENT 7 0.0064
86 ENDOCARDITIS BACTERIAL 5 0.0064
87 PRODUCT CONFUSION 5 0.0063
88 HYPERCHLORAEMIA 4 0.0063
89 SPUTUM CULTURE POSITIVE 5 0.0062
90 ASPERGILLOSIS 8 0.0061
91 HEPARIN-INDUCED THROMBOCYTOPENIA 30 0.0061
92 SEPTIC EMBOLUS 5 0.0060
93 ACUTE LEFT VENTRICULAR FAILURE 4 0.0060
94 ANHEDONIA 156 0.0059
95 STENOTROPHOMONAS INFECTION 8 0.0059
96 SURGICAL PROCEDURE REPEATED 4 0.0058
97 COAGULATION TIME PROLONGED 9 0.0058
98 FEAR OF DEATH 13 0.0058
99 PSEUDOMONAL SEPSIS 10 0.0057
100 TRANSFUSION REACTION 5 0.0057
101 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
102 TRYPTASE INCREASED 4 0.0056
103 LIP EROSION 4 0.0055
104 PNEUMONIA KLEBSIELLA 10 0.0054
105 PUPILLARY REFLEX IMPAIRED 10 0.0054
106 COMA HEPATIC 4 0.0054
107 HEART SOUNDS ABNORMAL 4 0.0053
108 MALIGNANT ASCITES 4 0.0052
109 HEPATIC NEOPLASM MALIGNANT 11 0.0052
110 CONTINUOUS HAEMODIAFILTRATION 5 0.0051
111 SUBCUTANEOUS EMPHYSEMA 5 0.0051
112 HYPOFIBRINOGENAEMIA 5 0.0050
113 DIABETES INSIPIDUS 12 0.0050
114 DISSEMINATED INTRAVASCULAR COAGULATION 70 0.0050
115 HYDROTHORAX 4 0.0048
116 ADRENAL SUPPRESSION 4 0.0047
117 RESPIRATORY RATE INCREASED 42 0.0047
118 ASCITES 139 0.0047
119 PANCREATIC CYST 9 0.0047
120 PROCEDURAL HYPOTENSION 4 0.0047
121 GENERALISED OEDEMA 58 0.0047
122 SLOW RESPONSE TO STIMULI 6 0.0046
123 HYPERNATRAEMIA 23 0.0046
124 HYPOVOLAEMIA 27 0.0046
125 PNEUMONIA FUNGAL 18 0.0046
126 PSEUDOMEMBRANOUS COLITIS 10 0.0045
127 HAEMODYNAMIC INSTABILITY 34 0.0045
128 TACHYARRHYTHMIA 11 0.0044
129 PO2 DECREASED 5 0.0043
130 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
131 BILIRUBIN CONJUGATED INCREASED 10 0.0043
132 BRASH SYNDROME 6 0.0043
133 FEBRILE INFECTION 5 0.0042
134 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0042
135 DELAYED RECOVERY FROM ANAESTHESIA 4 0.0042
136 PNEUMOCYSTIS JIROVECII INFECTION 5 0.0042
137 OLIGURIA 26 0.0042
138 SHOCK HAEMORRHAGIC 34 0.0042
139 HYPERURICAEMIA 17 0.0041
140 DUODENAL PERFORATION 4 0.0041
141 ORAL MUCOSA EROSION 5 0.0041
142 MATERNAL EXPOSURE DURING DELIVERY 4 0.0040
143 RALES 23 0.0040
144 KIDNEY TRANSPLANT REJECTION 19 0.0040
145 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 13 0.0039
146 STEVENS-JOHNSON SYNDROME 87 0.0039
147 ORAL MUCOSAL ERUPTION 6 0.0039
148 LIVER TRANSPLANT REJECTION 7 0.0039
149 CHEST INJURY 8 0.0039
150 OVARIAN HYPERSTIMULATION SYNDROME 9 0.0039
151 INJURY 270 0.0038
152 OSTEOSCLEROSIS 6 0.0038
153 HYPOPERFUSION 4 0.0038
154 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
155 CYTOKINE RELEASE SYNDROME 75 0.0037
156 PSEUDOMONAS INFECTION 32 0.0037
157 ANAPHYLACTIC SHOCK 96 0.0037
158 PRODUCT PACKAGING CONFUSION 9 0.0037
159 TYPE I HYPERSENSITIVITY 13 0.0037
160 BACTERIAL SEPSIS 12 0.0037
161 BLOOD CULTURE POSITIVE 11 0.0037
162 BLOOD ALBUMIN DECREASED 29 0.0037
163 ISCHAEMIC HEPATITIS 5 0.0036
164 HYPERCAPNIA 11 0.0036
165 NEPHROTIC SYNDROME 25 0.0036
166 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
167 RHONCHI 5 0.0036
168 MULTIPLE ORGAN DYSFUNCTION SYNDROME 102 0.0036
169 GASTRIC DILATATION 6 0.0036
170 SYSTEMIC CANDIDA 9 0.0036
171 OCCULT BLOOD POSITIVE 7 0.0036
172 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
173 SEPTIC SHOCK 154 0.0035
174 ACUTE RESPIRATORY FAILURE 68 0.0035
175 PNEUMATOSIS INTESTINALIS 10 0.0035
176 ESCHERICHIA SEPSIS 10 0.0034
177 ADENOVIRUS INFECTION 10 0.0034
178 SYSTEMIC MYCOSIS 4 0.0034
179 NODAL RHYTHM 5 0.0034
180 HYPOCHLORAEMIA 4 0.0034
181 INCISION SITE PAIN 4 0.0034
182 PANCREATITIS CHRONIC 8 0.0034
183 GASTROINTESTINAL WALL THICKENING 5 0.0033
184 SUSPECTED OFF LABEL USE 15 0.0033
185 UNEVALUABLE EVENT 251 0.0033
186 LARGE INTESTINAL ULCER 9 0.0033
187 IMMUNE-MEDIATED LUNG DISEASE 6 0.0033
188 HYPOXIA 115 0.0033
189 HYPERPHOSPHATAEMIA 7 0.0033
190 BREATH SOUNDS ABNORMAL 16 0.0032
191 CYANOSIS 51 0.0032
192 SHOCK 73 0.0032
193 NEONATAL DISORDER 5 0.0032
194 MECHANICAL VENTILATION 6 0.0032
195 MALLORY-WEISS SYNDROME 4 0.0031
196 CYTOMEGALOVIRUS VIRAEMIA 14 0.0031
197 RENAL FAILURE ACUTE 133 0.0031
198 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
199 ENTEROCOCCAL INFECTION 15 0.0031
200 HYPOKALAEMIA 143 0.0031
201 RENAL IMPAIRMENT 257 0.0031
202 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
203 STAPHYLOCOCCAL SEPSIS 15 0.0030
204 ANGIOPATHY 17 0.0030
205 HYPERTRANSAMINASAEMIA 21 0.0030
206 RESUSCITATION 5 0.0030
207 OLIGOHYDRAMNIOS 10 0.0030
208 BLOOD UREA INCREASED 50 0.0030
209 RENAL FAILURE 396 0.0030
210 ORGAN FAILURE 12 0.0030
211 CLOSTRIDIAL INFECTION 10 0.0030
212 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
213 PERITONEAL HAEMORRHAGE 4 0.0029
214 DIABETIC METABOLIC DECOMPENSATION 4 0.0029
215 HYPOCALCAEMIA 54 0.0029
216 ACUTE PULMONARY OEDEMA 16 0.0028
217 BRAIN OEDEMA 36 0.0028
218 CULTURE URINE POSITIVE 4 0.0028
219 JAUNDICE CHOLESTATIC 10 0.0028
220 EYE INFLAMMATION 27 0.0028
221 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
222 COAGULOPATHY 47 0.0028
223 TEMPERATURE INTOLERANCE 29 0.0028
224 FLUID INTAKE REDUCED 14 0.0028
225 COVID-19 PNEUMONIA 33 0.0028
226 GRAFT VERSUS HOST DISEASE 20 0.0028
227 BLOOD BILIRUBIN INCREASED 75 0.0028
228 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
229 ABDOMINAL INFECTION 7 0.0027
230 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
231 RESPIRATORY FAILURE 199 0.0027
232 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6 0.0027
233 OPPORTUNISTIC INFECTION 5 0.0027
234 HEPATIC ENCEPHALOPATHY 25 0.0027
235 PLEURAL EFFUSION 162 0.0027
236 EMBOLISM 22 0.0026
237 CYTOMEGALOVIRUS INFECTION 44 0.0026
238 VARICES OESOPHAGEAL 8 0.0026
239 PULMONARY OEDEMA 118 0.0026
240 BACTERAEMIA 31 0.0026
241 LYMPHOCYTE COUNT DECREASED 46 0.0026
242 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
243 NEPHROPATHY TOXIC 29 0.0026
244 CARDIOPULMONARY FAILURE 10 0.0026
245 FUNGAEMIA 4 0.0025
246 HEPATITIS E 4 0.0025
247 ACUTE LUNG INJURY 3 0.0025
248 CACHEXIA 13 0.0025
249 LUNG CONSOLIDATION 7 0.0025
250 TUMOUR LYSIS SYNDROME 22 0.0025
251 ENCEPHALOPATHY 61 0.0025
252 FOAMING AT MOUTH 5 0.0025
253 PORTAL VEIN THROMBOSIS 8 0.0025
254 OXYGEN SATURATION DECREASED 139 0.0025
255 DUODENAL ULCER HAEMORRHAGE 7 0.0024
256 OSTEOLYSIS 5 0.0024
257 AMYLASE INCREASED 9 0.0024
258 QUADRIPLEGIA 5 0.0024
259 SUFFOCATION FEELING 6 0.0024
260 PAPULE 17 0.0024
261 SKIN INDURATION 5 0.0024
262 VENA CAVA THROMBOSIS 4 0.0024
263 STEM CELL TRANSPLANT 6 0.0024
264 PROTEIN TOTAL DECREASED 9 0.0024
265 INTESTINAL ISCHAEMIA 13 0.0024
266 HEPATIC FAILURE 71 0.0024
267 SARS-COV-2 TEST POSITIVE 31 0.0023
268 PROTHROMBIN TIME PROLONGED 14 0.0023
269 BLOOD PH DECREASED 4 0.0023
270 HEPATOSPLENOMEGALY 6 0.0023
271 BLOOD AMYLASE INCREASED 4 0.0023
272 LYMPHOCYTOSIS 5 0.0023
273 BRONCHOPULMONARY ASPERGILLOSIS 18 0.0023
274 SKIN NECROSIS 12 0.0023
275 SPUTUM INCREASED 5 0.0023
276 OESOPHAGEAL VARICES HAEMORRHAGE 5 0.0023
277 COMPARTMENT SYNDROME 6 0.0023
278 EXTREMITY NECROSIS 4 0.0023
279 RENAL TUBULAR ACIDOSIS 5 0.0023
280 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
281 URINE OUTPUT DECREASED 20 0.0023
282 DUODENITIS 7 0.0023
283 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
284 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
285 NEUROLOGICAL SYMPTOM 13 0.0023
286 LARYNGEAL OEDEMA 14 0.0023
287 FIBRIN D DIMER INCREASED 8 0.0022
288 JUGULAR VEIN THROMBOSIS 4 0.0022
289 PARAPARESIS 4 0.0022
290 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
291 CONJUNCTIVAL HYPERAEMIA 8 0.0022
292 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
293 RENAL TUBULAR NECROSIS 22 0.0022
294 TRANSPLANT DYSFUNCTION 4 0.0022
295 MALNUTRITION 25 0.0022
296 RESPIRATORY RATE DECREASED 7 0.0022
297 DERMATITIS ALLERGIC 28 0.0022
298 HYPERBILIRUBINAEMIA 23 0.0022
299 ACUTE RESPIRATORY DISTRESS SYNDROME 39 0.0022
300 URINE ABNORMALITY 10 0.0022
301 MACULE 6 0.0022
302 WOUND HAEMORRHAGE 8 0.0022
303 GANGRENE 13 0.0022
304 SEPSIS 240 0.0021
305 FOETAL GROWTH RESTRICTION 13 0.0021
306 INTERVERTEBRAL DISCITIS 4 0.0021
307 CARDIAC FAILURE ACUTE 14 0.0021
308 CARDIOGENIC SHOCK 30 0.0021
309 RENAL FAILURE CHRONIC 16 0.0021
310 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
311 ATELECTASIS 20 0.0021
312 TRANSPLANT FAILURE 5 0.0020
313 HYPERVOLAEMIA 10 0.0020
314 AUTOIMMUNE HEPATITIS 14 0.0020
315 HYPERAMMONAEMIA 10 0.0020
316 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
317 VENOOCCLUSIVE DISEASE 5 0.0020
318 HEPATITIS CHOLESTATIC 12 0.0020
319 NEPHROGENIC SYSTEMIC FIBROSIS 6 0.0020
320 ASPERGILLUS INFECTION 13 0.0020
321 TOXIC ENCEPHALOPATHY 10 0.0020
322 ACIDOSIS 15 0.0020
323 PNEUMOTHORAX 31 0.0020
324 THROMBOTIC MICROANGIOPATHY 19 0.0019
325 CIRCULATORY COLLAPSE 33 0.0019
326 CONGESTIVE CARDIOMYOPATHY 8 0.0019
327 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
328 PULSE ABSENT 9 0.0019
329 BRONCHOSPASM 27 0.0019
330 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
331 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
332 AREFLEXIA 5 0.0019
333 ACUTE LEUKAEMIA 3 0.0019
334 HEPATIC FUNCTION ABNORMAL 69 0.0018
335 POLYURIA 15 0.0018
336 HEPATITIS B 11 0.0018
337 NEUTROPHIL COUNT DECREASED 74 0.0018
338 INFLAMMATORY MARKER INCREASED 9 0.0018
339 LUNG INFILTRATION 16 0.0018
340 BLOOD CREATINE INCREASED 8 0.0018
341 BACTERIAL TEST POSITIVE 4 0.0018
342 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
343 CHOLANGITIS 11 0.0018
344 HEPATOCELLULAR DAMAGE 4 0.0018
345 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
346 OXYGEN SATURATION ABNORMAL 5 0.0018
347 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
348 CHILLS 206 0.0018
349 ACUTE HEPATIC FAILURE 24 0.0018
350 CEREBRAL ATROPHY 7 0.0018
351 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
352 TRANSPLANT REJECTION 14 0.0017
353 PANCREATITIS NECROTISING 4 0.0017
354 PERIORBITAL OEDEMA 9 0.0017
355 ENTEROCOLITIS 10 0.0017
356 ASPARTATE AMINOTRANSFERASE INCREASED 92 0.0017
357 HEPATOMEGALY 17 0.0017
358 LOCALISED OEDEMA 8 0.0017
359 METHAEMOGLOBINAEMIA 4 0.0017
360 HYPOMAGNESAEMIA 24 0.0017
361 ELECTROLYTE IMBALANCE 20 0.0017
362 ANAPHYLACTIC REACTION 95 0.0017
363 PERIPHERAL ISCHAEMIA 7 0.0017
364 PULMONARY INFARCTION 4 0.0017
365 FEBRILE NEUTROPENIA 112 0.0017
366 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
367 RESPIRATORY DISTRESS 46 0.0017
368 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
369 BLOOD PRESSURE DECREASED 110 0.0017
370 HYPERKALAEMIA 58 0.0017
371 HYPOTENSION 331 0.0016
372 PATHOGEN RESISTANCE 15 0.0016
373 PSYCHIATRIC SYMPTOM 12 0.0016
374 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
375 HYPOPHOSPHATAEMIA 12 0.0016
376 SPLENOMEGALY 19 0.0016
377 PORTAL HYPERTENSION 5 0.0016
378 VENTRICULAR FIBRILLATION 18 0.0016
379 BODY TEMPERATURE INCREASED 33 0.0016
380 EMOTIONAL DISTRESS 195 0.0016
381 PROTEIN URINE PRESENT 8 0.0016
382 VENTRICULAR HYPERTROPHY 4 0.0016
383 EMPHYSEMA 16 0.0016
384 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
385 URINARY TRACT INFECTION BACTERIAL 4 0.0016
386 DYSPHORIA 8 0.0016
387 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
388 ORTHOPNOEA 5 0.0016
389 ILEUS PARALYTIC 7 0.0016
390 CUSHINGOID 5 0.0016
391 VENTRICULAR HYPOKINESIA 5 0.0016
392 BACTERIAL INFECTION 29 0.0016
393 AORTIC ARTERIOSCLEROSIS 4 0.0016
394 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
395 CONGENITAL ANOMALY 12 0.0015
396 LEUKOCYTOSIS 28 0.0015
397 HEPATIC CIRRHOSIS 29 0.0015
398 VASCULAR DEVICE INFECTION 7 0.0015
399 FACE OEDEMA 26 0.0015
400 PULMONARY HAEMORRHAGE 12 0.0015
401 TORSADE DE POINTES 12 0.0015
402 DRUG ERUPTION 27 0.0015
403 HYPOGAMMAGLOBULINAEMIA 10 0.0015
404 BLOOD LACTIC ACID INCREASED 8 0.0015
405 SERUM FERRITIN INCREASED 8 0.0015
406 OTITIS MEDIA 5 0.0015
407 ANURIA 13 0.0015
408 LOW BIRTH WEIGHT BABY 12 0.0015
409 ANXIETY DISORDER 5 0.0015
410 CANDIDIASIS 6 0.0015
411 BRADYPNOEA 4 0.0015
412 WOUND DEHISCENCE 5 0.0015
413 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
414 PURPURA 13 0.0015
415 NEUTROPHIL COUNT INCREASED 15 0.0015
416 HYPOVOLAEMIC SHOCK 7 0.0015
417 BRONCHOPNEUMONIA 5 0.0015
418 LEFT VENTRICULAR FAILURE 5 0.0015
419 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
420 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
421 STILLBIRTH 7 0.0014
422 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0014
423 LIPASE INCREASED 11 0.0014
424 UNRESPONSIVE TO STIMULI 37 0.0014
425 ENDOTRACHEAL INTUBATION 4 0.0014
426 HAEMOLYSIS 11 0.0014
427 SKIN HYPERTROPHY 4 0.0014
428 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
429 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
430 BLOOD CREATININE INCREASED 92 0.0014
431 HEPATITIS C 17 0.0014
432 CARDIAC FAILURE 113 0.0014
433 HYPOTHERMIA 14 0.0014
434 POLYP 9 0.0014
435 NEUROTOXICITY 24 0.0014
436 PLATELET COUNT DECREASED 145 0.0014
437 IMMUNOSUPPRESSION 12 0.0014
438 CARDIOMYOPATHY 20 0.0014
439 HEPATITIS FULMINANT 4 0.0013
440 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
441 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
442 HYPONATRAEMIA 74 0.0013
443 HAEMODIALYSIS 11 0.0013
444 OEDEMA 71 0.0013
445 FIBROSIS 4 0.0013
446 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
447 LARGE INTESTINE PERFORATION 9 0.0013
448 NEPHROGENIC ANAEMIA 6 0.0013
449 TACHYCARDIA 115 0.0013
450 ILEUS 16 0.0013
451 BLOOD BLISTER 4 0.0013
452 STAPHYLOCOCCAL INFECTION 42 0.0013
453 HAEMORRHAGE INTRACRANIAL 19 0.0013
454 SINUS TACHYCARDIA 18 0.0013
455 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
456 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
457 HAEMATOCRIT DECREASED 25 0.0013
458 CHEST DISCOMFORT 129 0.0013
459 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
460 PNEUMONIA VIRAL 4 0.0013
461 METABOLIC ACIDOSIS 40 0.0012
462 DERMATITIS BULLOUS 9 0.0012
463 CYSTITIS HAEMORRHAGIC 5 0.0012
464 FLUID OVERLOAD 18 0.0012
465 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
466 DECUBITUS ULCER 10 0.0012
467 JAUNDICE 33 0.0012
468 PANCYTOPENIA 68 0.0012
469 ANAPHYLACTOID REACTION 5 0.0012
470 CYTOLYTIC HEPATITIS 4 0.0012
471 LYMPHOPENIA 17 0.0012
472 HYPERTRIGLYCERIDAEMIA 7 0.0012
473 BK VIRUS INFECTION 4 0.0012
474 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
475 PNEUMONITIS 32 0.0012
476 CARDIAC ARREST 97 0.0012
477 THROMBOCYTOPENIA 130 0.0012
478 PNEUMONIA ASPIRATION 29 0.0012
479 FAILURE TO THRIVE 6 0.0012
480 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
481 PYREXIA 396 0.0011
482 MYOCARDIAL ISCHAEMIA 13 0.0011
483 MYELOSUPPRESSION 41 0.0011
484 DEPRESSIVE SYMPTOM 4 0.0011
485 HYPERCALCAEMIA 14 0.0011
486 RASH ERYTHEMATOUS 54 0.0011
487 DIALYSIS 16 0.0011
488 C-REACTIVE PROTEIN INCREASED 41 0.0011
489 CANDIDA INFECTION 19 0.0011
490 PERICARDIAL EFFUSION 26 0.0011
491 PRODUCT CONTAMINATION 4 0.0011
492 MYASTHENIA GRAVIS 9 0.0011
493 RENAL TRANSPLANT 4 0.0011
494 SCLERODERMA 4 0.0011
495 LEUKOPENIA 55 0.0011
496 ACUTE KIDNEY INJURY 168 0.0011
497 HYPERGLYCAEMIA 40 0.0011
498 BLOOD PHOSPHORUS DECREASED 4 0.0011
499 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
500 MOUTH HAEMORRHAGE 8 0.0011
501 LUMBAR VERTEBRAL FRACTURE 5 0.0011
502 PNEUMONIA BACTERIAL 10 0.0011
503 RASH MACULO-PAPULAR 24 0.0011
504 NECROSIS 6 0.0011
505 ERYTHEMA MULTIFORME 10 0.0011
506 PREMATURE DELIVERY 17 0.0011
507 DELIRIUM 37 0.0011
508 SKIN TIGHTNESS 5 0.0011
509 REBOUND EFFECT 12 0.0011
510 CYTOPENIA 13 0.0011
511 ALTERED STATE OF CONSCIOUSNESS 23 0.0011
512 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
513 ADVERSE REACTION 14 0.0011
514 ANAEMIA 201 0.0011
515 TROPONIN INCREASED 8 0.0011
516 HYPERTHERMIA 8 0.0010
517 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
518 COLITIS ISCHAEMIC 7 0.0010
519 HEART RATE INCREASED 102 0.0010
520 VENTRICULAR TACHYCARDIA 17 0.0010
521 PRODUCT LABEL CONFUSION 6 0.0010
522 EPIGASTRIC DISCOMFORT 4 0.0010
523 ECCHYMOSIS 7 0.0010
524 VENOUS THROMBOSIS 4 0.0010
525 TRICUSPID VALVE INCOMPETENCE 8 0.0010
526 CARDIO-RESPIRATORY ARREST 42 0.0010
527 ANAL INCONTINENCE 9 0.0010
528 RIGHT VENTRICULAR FAILURE 7 0.0010
529 URINARY RETENTION 33 0.0010
530 ADRENAL INSUFFICIENCY 12 0.0010
531 HEPATOTOXICITY 22 0.0010
532 PULMONARY CONGESTION 13 0.0010
533 NEUTROPENIC SEPSIS 7 0.0010
534 WHITE BLOOD CELL COUNT DECREASED 106 0.0010
535 CARDIOMEGALY 12 0.0010
536 ENDOCARDITIS 5 0.0010
537 THYROID DISORDER 15 0.0010
538 PERIPHERAL VASCULAR DISORDER 5 0.0010
539 EUGLYCAEMIC DIABETIC KETOACIDOSIS 4 0.0010
540 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
541 LIP OEDEMA 4 0.0009
542 FEBRILE BONE MARROW APLASIA 4 0.0009
543 MENTAL STATUS CHANGES 26 0.0009
544 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
545 ANXIETY 263 0.0009
546 PERITONITIS 19 0.0009
547 ASPIRATION 10 0.0009
548 PROCEDURAL COMPLICATION 7 0.0009
549 PULMONARY HYPERTENSION 19 0.0009
550 ABDOMINAL ABSCESS 4 0.0009
551 GASTRIC ULCER HAEMORRHAGE 5 0.0009
552 LIVER DISORDER 40 0.0009
553 PREMATURE BABY 27 0.0009
554 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
555 HAEMOGLOBIN DECREASED 92 0.0009
556 GASTROINTESTINAL INFECTION 8 0.0009
557 NEOPLASM PROGRESSION 31 0.0009
558 WRONG PRODUCT ADMINISTERED 6 0.0009
559 MITRAL VALVE INCOMPETENCE 10 0.0009
560 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 48 0.0009
561 THERAPY NON-RESPONDER 39 0.0009
562 LACTIC ACIDOSIS 28 0.0009
563 MELAENA 19 0.0009
564 POST PROCEDURAL HAEMORRHAGE 10 0.0009
565 PNEUMONIA 278 0.0009
566 HICCUPS 7 0.0009
567 INTERNATIONAL NORMALISED RATIO INCREASED 24 0.0008
568 CARDIAC TAMPONADE 4 0.0008
569 HYPERLIPIDAEMIA 10 0.0008
570 LUNG INFECTION 13 0.0008
571 BRADYCARDIA 44 0.0008
572 RASH VESICULAR 4 0.0008
573 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
574 JOINT RANGE OF MOTION DECREASED 11 0.0008
575 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
576 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
577 DIABETIC NEUROPATHY 4 0.0008
578 PYELONEPHRITIS 7 0.0008
579 DRUG TOXICITY 11 0.0008
580 INTESTINAL PERFORATION 9 0.0008
581 PANCREATITIS ACUTE 18 0.0008
582 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
583 PROTEINURIA 15 0.0008
584 BONE MARROW FAILURE 16 0.0008
585 INFUSION RELATED REACTION 52 0.0008
586 CHOLESTASIS 15 0.0008
587 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
588 MYDRIASIS 10 0.0008
589 CEREBRAL INFARCTION 19 0.0008
590 EYELID OEDEMA 9 0.0008
591 SKIN ULCER 20 0.0008
592 VASCULITIS 9 0.0008
593 ATRIAL FIBRILLATION 75 0.0008
594 ACUTE MYELOID LEUKAEMIA 12 0.0008
595 PETECHIAE 8 0.0008
596 APLASTIC ANAEMIA 4 0.0008
597 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
598 COMA 36 0.0008
599 CHROMATURIA 17 0.0008
600 VIROLOGIC FAILURE 4 0.0007
601 GINGIVITIS 4 0.0007
602 PANCREATITIS 39 0.0007
603 DRUG-INDUCED LIVER INJURY 23 0.0007
604 ESCHERICHIA INFECTION 6 0.0007
605 POST PROCEDURAL COMPLICATION 14 0.0007
606 PERIPHERAL COLDNESS 10 0.0007
607 MUCOSAL INFLAMMATION 19 0.0007
608 ENCEPHALITIS 5 0.0007
609 BLOOD TEST ABNORMAL 10 0.0007
610 GRANULOCYTOPENIA 4 0.0007
611 INTERSTITIAL LUNG DISEASE 34 0.0007
612 CHOLELITHIASIS 23 0.0007
613 HAEMATURIA 24 0.0007
614 DRUG RESISTANCE 18 0.0007
615 CARDIAC VALVE DISEASE 4 0.0007
616 RHABDOMYOLYSIS 29 0.0007
617 PSYCHOLOGICAL TRAUMA 6 0.0007
618 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
619 MYOPATHY 6 0.0007
620 HERPES VIRUS INFECTION 4 0.0007
621 METABOLIC DISORDER 4 0.0007
622 DISEASE PROGRESSION 80 0.0007
623 URINARY INCONTINENCE 20 0.0007
624 PLEURISY 4 0.0007
625 HAEMOLYTIC ANAEMIA 6 0.0007
626 HYDRONEPHROSIS 5 0.0007
627 DYSPNOEA 377 0.0007
628 GENERAL PHYSICAL HEALTH DETERIORATION 77 0.0007
629 PALLOR 18 0.0007
630 ABDOMINAL DISTENSION 69 0.0007
631 HEPATOCELLULAR CARCINOMA 5 0.0007
632 ARRHYTHMIA 31 0.0007
633 RESPIRATORY DEPRESSION 8 0.0007
634 MATERNAL EXPOSURE DURING PREGNANCY 58 0.0007
635 DEVICE RELATED INFECTION 10 0.0006
636 HAEMOPTYSIS 18 0.0006
637 APNOEA 5 0.0006
638 DEFORMITY 6 0.0006
639 OEDEMA PERIPHERAL 77 0.0006
640 HAEMATEMESIS 16 0.0006
641 RENAL CYST 5 0.0006
642 ATRIAL FLUTTER 5 0.0006
643 BLOOD CALCIUM DECREASED 7 0.0006
644 HYPERTHYROIDISM 9 0.0006
645 LIVER FUNCTION TEST ABNORMAL 18 0.0006
646 HIATUS HERNIA 8 0.0006
647 HERPES SIMPLEX 4 0.0006
648 CEREBRAL HAEMORRHAGE 22 0.0006
649 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
650 ORAL CANDIDIASIS 8 0.0006
651 WHEEZING 36 0.0006
652 DISABILITY 12 0.0006
653 MENINGITIS 4 0.0006
654 URTICARIA 100 0.0006
655 NEUTROPENIA 81 0.0006
656 PERITONITIS BACTERIAL 6 0.0006
657 RED BLOOD CELL COUNT DECREASED 17 0.0006
658 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
659 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
660 MOTOR DYSFUNCTION 6 0.0006
661 HAEMORRHAGE 61 0.0006
662 RESPIRATION ABNORMAL 4 0.0006
663 EJECTION FRACTION DECREASED 9 0.0006
664 HAEMATOMA 15 0.0006
665 VENTRICULAR EXTRASYSTOLES 6 0.0006
666 NERVOUS SYSTEM DISORDER 18 0.0006
667 HYPERSENSITIVITY 107 0.0006
668 NO THERAPEUTIC RESPONSE 7 0.0006
669 DISCOMFORT 35 0.0006
670 TRANSFUSION 6 0.0006
671 RESPIRATORY DISORDER 17 0.0006
672 DUODENAL ULCER 4 0.0006
673 BLOOD POTASSIUM DECREASED 17 0.0006
674 DIVERTICULUM 4 0.0006
675 CONVULSION 32 0.0006
676 SUBDURAL HAEMATOMA 8 0.0006
677 BLOOD POTASSIUM INCREASED 9 0.0006
678 INFECTION 80 0.0006
679 WOUND INFECTION 6 0.0005
680 GRAND MAL CONVULSION 5 0.0005
681 HEART RATE DECREASED 19 0.0005
682 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
683 CARDIAC FAILURE CONGESTIVE 43 0.0005
684 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
685 STATUS EPILEPTICUS 6 0.0005
686 PAIN 326 0.0005
687 HAEMATOTOXICITY 5 0.0005
688 AORTIC ANEURYSM 4 0.0005
689 SCAR 9 0.0005
690 GASTRIC HAEMORRHAGE 6 0.0005
691 PRURITUS 199 0.0005
692 ATRIOVENTRICULAR BLOCK 4 0.0005
693 BLOOD PRESSURE INCREASED 79 0.0005
694 FOETAL EXPOSURE DURING PREGNANCY 42 0.0005
695 VITAMIN D DEFICIENCY 5 0.0005
696 CARDIOVASCULAR DISORDER 13 0.0005
697 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
698 RESPIRATORY ARREST 14 0.0005
699 PULMONARY EMBOLISM 48 0.0005
700 GALLBLADDER DISORDER 9 0.0005
701 POLYNEUROPATHY 6 0.0005
702 TRANSAMINASES INCREASED 11 0.0005
703 GASTRITIS 13 0.0005
704 HEPATOCELLULAR INJURY 7 0.0005
705 DEEP VEIN THROMBOSIS 32 0.0005
706 ERYTHEMA 101 0.0005
707 HYPERTENSION 104 0.0005
708 SUBARACHNOID HAEMORRHAGE 5 0.0005
709 EPILEPSY 15 0.0005
710 SMALL INTESTINAL OBSTRUCTION 6 0.0005
711 SPINAL COMPRESSION FRACTURE 4 0.0005
712 MENTAL DISORDER 21 0.0005
713 HEMIPLEGIA 4 0.0005
714 EOSINOPHIL COUNT INCREASED 4 0.0005
715 ACUTE MYOCARDIAL INFARCTION 14 0.0005
716 MOUTH ULCERATION 10 0.0005
717 GASTRIC ULCER 9 0.0005
718 PALPITATIONS 55 0.0005
719 LUNG DISORDER 23 0.0005
720 URINARY TRACT INFECTION 79 0.0005
721 HAEMORRHOIDS 9 0.0005
722 RASH 200 0.0005
723 DEPRESSION 104 0.0005
724 EOSINOPHILIA 8 0.0005
725 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
726 OFF LABEL USE 390 0.0004
727 CONFUSIONAL STATE 71 0.0004
728 RESTLESSNESS 16 0.0004
729 MYOCARDITIS 5 0.0004
730 FLANK PAIN 4 0.0004
731 ARTERIOSCLEROSIS 4 0.0004
732 LYMPHADENOPATHY 15 0.0004
733 FLUSHING 43 0.0004
734 RETCHING 9 0.0004
735 SPUTUM DISCOLOURED 4 0.0004
736 PRODUCT PACKAGING ISSUE 4 0.0004
737 RECTAL HAEMORRHAGE 18 0.0004
738 EXPOSURE DURING PREGNANCY 26 0.0004
739 MUSCLE RIGIDITY 5 0.0004
740 DRUG INTERACTION 66 0.0004
741 EPISTAXIS 31 0.0004
742 HYPERCHOLESTEROLAEMIA 4 0.0004
743 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
744 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
745 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
746 FLATULENCE 23 0.0004
747 CONTUSION 39 0.0004
748 ABDOMINAL PAIN 94 0.0004
749 TREATMENT NONCOMPLIANCE 22 0.0004
750 RASH PAPULAR 9 0.0004
751 HYPOTONIA 4 0.0004
752 BRAIN INJURY 4 0.0004
753 PRODUCTIVE COUGH 19 0.0004
754 INTESTINAL OBSTRUCTION 15 0.0004
755 TOXIC SKIN ERUPTION 4 0.0004
756 CELLULITIS 20 0.0004
757 COLITIS 15 0.0004
758 ABDOMINAL PAIN LOWER 10 0.0004
759 BLISTER 22 0.0004
760 CEREBROVASCULAR ACCIDENT 66 0.0004
761 ANOREXIA 5 0.0004
762 RASH PRURITIC 21 0.0004
763 DEHYDRATION 51 0.0004
764 DIABETES MELLITUS 29 0.0004
765 HYPERHIDROSIS 49 0.0004
766 INCONTINENCE 4 0.0004
767 CONJUNCTIVITIS 7 0.0004
768 AGRANULOCYTOSIS 7 0.0004
769 LOSS OF CONSCIOUSNESS 48 0.0004
770 PHOTOPHOBIA 7 0.0004
771 POOR QUALITY SLEEP 8 0.0004
772 PRODUCT USE IN UNAPPROVED INDICATION 92 0.0004
773 HYPOGLYCAEMIA 18 0.0004
774 MUSCLE TIGHTNESS 6 0.0004
775 BLOOD URINE PRESENT 7 0.0004
776 LIVER INJURY 9 0.0004
777 GASTROINTESTINAL PAIN 4 0.0004
778 CORONARY ARTERY DISEASE 11 0.0004
779 TREATMENT FAILURE 30 0.0004
780 FEELING COLD 10 0.0004
781 SKIN REACTION 5 0.0004
782 COUGH 98 0.0003
783 PARALYSIS 5 0.0003
784 MUSCLE TWITCHING 8 0.0003
785 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
786 STOMATITIS 21 0.0003
787 HALLUCINATION 26 0.0003
788 HYPOTHYROIDISM 11 0.0003
789 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
790 COLD SWEAT 6 0.0003
791 CHOLECYSTITIS 4 0.0003
792 CONDITION AGGRAVATED 101 0.0003
793 HYPOAESTHESIA ORAL 5 0.0003
794 DIARRHOEA 214 0.0003
795 OSTEOMYELITIS 6 0.0003
796 FUNGAL INFECTION 11 0.0003
797 ECONOMIC PROBLEM 5 0.0003
798 OSTEOPENIA 5 0.0003
799 SEIZURE 38 0.0003
800 DYSPHAGIA 31 0.0003
801 TREMOR 54 0.0003
802 LYMPHOMA 5 0.0003
803 HEPATIC ENZYME INCREASED 22 0.0003
804 BLOOD SODIUM DECREASED 6 0.0003
805 HYPOPHAGIA 8 0.0003
806 HEPATITIS 8 0.0003
807 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
808 HAEMATOCHEZIA 17 0.0003
809 RESPIRATORY TRACT INFECTION 8 0.0003
810 NERVOUSNESS 16 0.0003
811 LABORATORY TEST ABNORMAL 9 0.0003
812 EYE DISORDER 10 0.0003
813 IMMUNE SYSTEM DISORDER 4 0.0003
814 SKIN DISORDER 10 0.0003
815 DYSURIA 11 0.0003
816 CHEST PAIN 55 0.0003
817 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
818 AGITATION 21 0.0003
819 METASTASES TO LIVER 5 0.0003
820 COVID-19 49 0.0003
821 RENAL DISORDER 13 0.0003
822 DISORIENTATION 11 0.0003
823 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
824 END STAGE RENAL DISEASE 5 0.0003
825 DEATH 234 0.0003
826 VOMITING 127 0.0003
827 MEDICATION ERROR 15 0.0003
828 HEPATIC STEATOSIS 5 0.0003
829 LUNG NEOPLASM MALIGNANT 11 0.0003
830 THROAT IRRITATION 12 0.0003
831 DECREASED APPETITE 62 0.0003
832 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
833 INSURANCE ISSUE 4 0.0003
834 RASH MACULAR 9 0.0003
835 THERAPY PARTIAL RESPONDER 4 0.0003
836 SWOLLEN TONGUE 8 0.0003
837 FLUID RETENTION 13 0.0003
838 MUSCULAR WEAKNESS 29 0.0003
839 KIDNEY INFECTION 5 0.0003
840 DISEASE RECURRENCE 12 0.0003
841 BLOOD PRESSURE ABNORMAL 5 0.0003
842 ULCER 4 0.0003
843 DIABETIC KETOACIDOSIS 6 0.0002
844 SPEECH DISORDER 13 0.0002
845 PRESYNCOPE 6 0.0002
846 DRUG INEFFECTIVE 324 0.0002
847 ANGINA PECTORIS 7 0.0002
848 HERPES ZOSTER 14 0.0002
849 NAUSEA 192 0.0002
850 DRUG LEVEL INCREASED 4 0.0002
851 NEPHROLITHIASIS 11 0.0002
852 ASTHENIA 89 0.0002
853 HEMIPARESIS 4 0.0002
854 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
855 FAECES DISCOLOURED 5 0.0002
856 SWELLING FACE 15 0.0002
857 PAIN OF SKIN 6 0.0002
858 BONE PAIN 13 0.0002
859 HEART RATE IRREGULAR 5 0.0002
860 TOXICITY TO VARIOUS AGENTS 37 0.0002
861 MYOCARDIAL INFARCTION 38 0.0002
862 ADVERSE EVENT 20 0.0002
863 SLEEP APNOEA SYNDROME 4 0.0002
864 BACK PAIN 48 0.0002
865 CONSTIPATION 45 0.0002
866 DYSPHONIA 12 0.0002
867 ASTHMA 23 0.0002
868 CARDIAC DISORDER 19 0.0002
869 BRONCHITIS 15 0.0002
870 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
871 SYNCOPE 20 0.0002
872 APHASIA 6 0.0002
873 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
874 THERAPEUTIC RESPONSE DECREASED 12 0.0002
875 DRY MOUTH 16 0.0002
876 SKIN DISCOLOURATION 9 0.0002
877 MOBILITY DECREASED 14 0.0002
878 EMOTIONAL DISORDER 6 0.0002
879 LIMB DISCOMFORT 6 0.0002
880 POLLAKIURIA 8 0.0002
881 ACCIDENTAL OVERDOSE 7 0.0002
882 DERMATITIS 4 0.0002
883 JOINT STIFFNESS 5 0.0002
884 EYE SWELLING 7 0.0002
885 DRUG INTOLERANCE 18 0.0002
886 DYSARTHRIA 7 0.0002
887 DYSPNOEA EXERTIONAL 7 0.0002
888 PRURITUS GENERALISED 4 0.0002
889 PRODUCT DISPENSING ERROR 4 0.0002
890 PRODUCT PRESCRIBING ISSUE 4 0.0002
891 SKIN LESION 5 0.0002
892 OVERDOSE 39 0.0002
893 BLOOD GLUCOSE INCREASED 34 0.0002
894 VIRAL INFECTION 6 0.0002
895 LIP SWELLING 6 0.0002
896 COLITIS ULCERATIVE 8 0.0002
897 PRODUCT AVAILABILITY ISSUE 4 0.0002
898 WEIGHT INCREASED 39 0.0002
899 LETHARGY 10 0.0002
900 BLINDNESS 7 0.0002
901 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
902 OCULAR HYPERAEMIA 8 0.0002
903 FALL 56 0.0002
904 BLOOD PRESSURE FLUCTUATION 4 0.0002
905 MENTAL IMPAIRMENT 4 0.0002
906 BALANCE DISORDER 14 0.0002
907 NO ADVERSE EVENT 29 0.0002
908 CHRONIC KIDNEY DISEASE 12 0.0002
909 MOVEMENT DISORDER 5 0.0002
910 HYPOAESTHESIA 23 0.0002
911 ECZEMA 8 0.0002
912 ABNORMAL BEHAVIOUR 6 0.0002
913 NEOPLASM MALIGNANT 10 0.0001
914 SWELLING 14 0.0001
915 FREQUENT BOWEL MOVEMENTS 4 0.0001
916 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
917 PANCREATIC CARCINOMA 4 0.0001
918 THERAPY CESSATION 7 0.0001
919 FATIGUE 106 0.0001
920 ANGIOEDEMA 6 0.0001
921 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
922 SKIN EXFOLIATION 11 0.0001
923 INJECTION SITE RASH 4 0.0001
924 MYALGIA 22 0.0001
925 WEIGHT DECREASED 36 0.0001
926 BURNING SENSATION 9 0.0001
927 NEUROPATHY PERIPHERAL 12 0.0001
928 CYSTITIS 4 0.0001
929 GASTROINTESTINAL DISORDER 11 0.0001
930 IMPAIRED HEALING 4 0.0001
931 PRODUCT USE ISSUE 22 0.0001
932 DIZZINESS 58 0.0001
933 INFLAMMATION 6 0.0001
934 VAGINAL HAEMORRHAGE 5 0.0001
935 GAIT DISTURBANCE 22 0.0001
936 FEELING HOT 7 0.0001
937 THROMBOSIS 9 0.0001
938 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
939 PERIPHERAL SWELLING 17 0.0001
940 SOMNOLENCE 22 0.0001
941 AMNESIA 7 0.0001
942 NECK PAIN 6 0.0001
943 MALAISE 46 0.0001
944 EYE IRRITATION 6 0.0001
945 PLASMA CELL MYELOMA 4 0.0001
946 PAIN IN EXTREMITY 30 0.0001
947 AGGRESSION 5 0.0001
948 DYSKINESIA 4 0.0001
949 THERAPY INTERRUPTED 7 0.0001
950 OSTEOPOROSIS 4 0.0001
951 VISION BLURRED 13 0.0001
952 INSOMNIA 25 0.0001
953 INTENTIONAL OVERDOSE 6 0.0001
954 DYSPEPSIA 9 0.0001
955 DRY SKIN 12 0.0001
956 INFLUENZA 10 0.0001
957 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
958 PARAESTHESIA 14 0.0001
959 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
960 EYE PAIN 5 0.0001
961 COGNITIVE DISORDER 4 0.0001
962 INFLUENZA LIKE ILLNESS 7 0.0001
963 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
964 BLOOD GLUCOSE DECREASED 4 0.0001
965 ILL-DEFINED DISORDER 5 0.0001
966 MEMORY IMPAIRMENT 11 0.0001
967 RHEUMATOID ARTHRITIS 9 0.0001
968 ABDOMINAL DISCOMFORT 13 0.0001
969 HEADACHE 47 0.0001
970 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
971 MUSCULOSKELETAL STIFFNESS 6 0.0001
972 SURGERY 4 0.0001
973 NASAL CONGESTION 4 0.0001
974 ABDOMINAL PAIN UPPER 14 0.0001
975 ADVERSE DRUG REACTION 6 0.0001
976 MUSCLE SPASMS 12 0.0001
977 OROPHARYNGEAL PAIN 6 0.0001
978 ARTHRITIS 5 0.0001
979 RHINORRHOEA 4 0.0001
980 FEELING ABNORMAL 14 0.0001
981 SLEEP DISORDER 4 0.0001
982 INCORRECT DOSE ADMINISTERED 12 0.0001
983 PRODUCT QUALITY ISSUE 7 0.0001
984 NASOPHARYNGITIS 9 0.0000
985 SINUSITIS 5 0.0000
986 ILLNESS 5 0.0000
987 PRODUCT DOSE OMISSION ISSUE 14 0.0000
988 ALOPECIA 9 0.0000
989 VISUAL IMPAIRMENT 5 0.0000
990 ACNE 3 0.0000
991 HOSPITALISATION 6 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
993 ARTHRALGIA 12 0.0000
994 INJECTION SITE PAIN 5 0.0000